Grantham, Mayo, Van Otterloo & Co (GMO)’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,100
Closed -$713K 855
2020
Q4
$713K Sell
7,100
-64,500
-90% -$4.81M ﹤0.01% 624
2020
Q3
$3.5M Buy
71,600
+18,400
+35% +$884K 0.02% 297
2020
Q2
$2.17M Sell
53,200
-43,200
-45% -$1.24M 0.02% 397
2020
Q1
$1.49M Buy
+96,400
New +$2.03M 0.01% 443

Other funds holding CRNC

Grantham, Mayo, Van Otterloo & Co (GMO)'s CRNC Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cerence (CRNC) in Q1 2021, closing a stake of 7,100 shares — an estimated $713K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRNC in Q1 2020 and held it in 4 quarters. The position peaked at $3.5M in Q3 2020. 320 funds tracked by Wall St. Rank hold CRNC as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cerence position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,100 Cerence shares in Q1 2021, an estimated $713K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cerence in Q1 2020 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cerence position peaked at $3.5M in Q3 2020.
  • 320 funds tracked by Wall St. Rank held Cerence as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.